IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $534,398 | +63067.6% | 55,493 | -25.2% | 0.00% | -57.1% |
| Q4 2022 | $846 | -99.9% | 74,140 | -24.4% | 0.01% | -22.2% |
| Q3 2022 | $1,031,000 | -30.1% | 98,127 | -22.1% | 0.01% | -25.0% |
| Q2 2022 | $1,475,000 | -79.8% | 125,972 | -79.3% | 0.01% | -77.4% |
| Q1 2022 | $7,305,000 | +8.8% | 607,247 | +0.7% | 0.05% | +8.2% |
| Q4 2021 | $6,717,000 | +3.2% | 602,957 | +20.7% | 0.05% | +25.6% |
| Q3 2021 | $6,510,000 | -3.6% | 499,587 | -3.9% | 0.04% | -2.5% |
| Q2 2021 | $6,756,000 | +110.6% | 519,697 | +79.8% | 0.04% | +110.5% |
| Q1 2021 | $3,208,000 | +52.9% | 288,977 | +42.4% | 0.02% | +46.2% |
| Q4 2020 | $2,098,000 | +223.8% | 202,866 | +201.9% | 0.01% | +160.0% |
| Q3 2020 | $648,000 | +27.6% | 67,196 | +30.9% | 0.01% | +25.0% |
| Q2 2020 | $508,000 | -16.2% | 51,323 | -12.9% | 0.00% | -33.3% |
| Q1 2020 | $606,000 | – | 58,922 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |